Literature DB >> 25929435

Higenamine regulates Nrf2-HO-1-Hmgb1 axis and attenuates intestinal ischemia-reperfusion injury in mice.

Chao Liu1, Chenyu Zhu, Guangsheng Wang, Rui Xu, Yaoming Zhu.   

Abstract

INTRODUCTION: Intestinal ischemia and reperfusion (IR) syndrome is a life-threatening dilemma caused by diverse events. Higenamine (HG), an active ingredient of Aconiti Lateralis Radix Praeparata, has been traditionally used as a heart stimulant and anti-inflammatory agent in oriental countries. But the function of HG on intestine IR injury has never been investigated.
MATERIALS AND METHODS: Mice underwent a 2 cm midline laparotomy, and the superior mesenteric artery (SMA) was obstructed by micro-vascular clamp to induce intestinal ischemia.
RESULTS: In our current study, HG increases mouse intestinal epithelial (IEC-6) cell viability through induced heme oxygenase-1 (HO-1) production in vitro. In our in vivo murine intestinal IR injury model, the increased HO-1 protein level and activity, decreased intestinal injury score, Myeloperoxidase (MPO) activity, and inflammatory cytokine expression induced by HG were all abolished with additional treatment of HO-1 inhibitor zinc protoporphyrin IX (ZnPPIX). Furthermore, HG reduced high mobility group box-1 (Hmgb1) expression in IR injury-performed intestine which was inhibited by additional administration of ZnPPIX. And HG treatment significantly decreased HO-1 expression in nuclear factor erythroid 2-related factor (Nrf-2) SiRNA-transfected cells but not in control SiRNA-transfected cells.
CONCLUSION: Our study provides evidence HG regulates Nrf2-HO-1-Hmgb1 axis and attenuates intestinal IR injury in mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25929435     DOI: 10.1007/s00011-015-0817-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  39 in total

Review 1.  Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.

Authors:  Helena Erlandsson Harris; Ulf Andersson
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

Review 2.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

Review 3.  Treating patients with severe sepsis.

Authors:  A P Wheeler; G R Bernard
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

Review 4.  Regulation of heme oxygenase gene expression.

Authors:  S Shibahara
Journal:  Semin Hematol       Date:  1988-10       Impact factor: 3.851

5.  Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways.

Authors:  Yu Mi Ha; Min Young Kim; Min Kyu Park; Young Soo Lee; Young Min Kim; Hye Jung Kim; Jae Heun Lee; Ki Churl Chang
Journal:  Apoptosis       Date:  2012-05       Impact factor: 4.677

6.  Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infections.

Authors:  M P Fink
Journal:  Crit Care Med       Date:  1995-06       Impact factor: 7.598

Review 7.  HMGB1 and RAGE in inflammation and cancer.

Authors:  Gary P Sims; Daniel C Rowe; Svend T Rietdijk; Ronald Herbst; Anthony J Coyle
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model.

Authors:  Fabienne Tamion; Vincent Richard; Sylvanie Renet; Christian Thuillez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-06       Impact factor: 4.052

9.  Effects of L-arginine infusion during ischemia on gut blood perfusion, oxygen tension, and circulating myeloid cell activation in a murine gut ischemia/reperfusion model.

Authors:  Kazuhiko Fukatsu; Chikara Ueno; Yoshinori Maeshima; Etsuko Hara; Hidetoshi Nagayoshi; Jiro Omata; Hidetaka Mochizuki; Hoshio Hiraide
Journal:  JPEN J Parenter Enteral Nutr       Date:  2004 Jul-Aug       Impact factor: 4.016

10.  The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Authors:  Lee-Wei Chen; Laurence Egan; Zhi-Wei Li; Florian R Greten; Martin F Kagnoff; Michael Karin
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

View more
  15 in total

1.  MicroRNA-351-5p aggravates intestinal ischaemia/reperfusion injury through the targeting of MAPK13 and Sirtuin-6.

Authors:  Yupeng Hu; Xufeng Tao; Xu Han; Lina Xu; Lianhong Yin; Huijun Sun; Yan Qi; Youwei Xu; Jinyong Peng
Journal:  Br J Pharmacol       Date:  2018-07-26       Impact factor: 8.739

2.  Bacteroides fragilis Enterotoxin Upregulates Heme Oxygenase-1 in Intestinal Epithelial Cells via a Mitogen-Activated Protein Kinase- and NF-κB-Dependent Pathway, Leading to Modulation of Apoptosis.

Authors:  Su Hyuk Ko; Da Jeong Rho; Jong Ik Jeon; Young-Jeon Kim; Hyun Ae Woo; Yun Kyung Lee; Jung Mogg Kim
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

3.  Anticancer effect of fufang yiliu yin on human hepatocellular carcinoma SMMC-7721 cells.

Authors:  Zhenjie Yang; Shigao Zhu; Shihai Liu; Xue Wang; Bing Han; Bingyuan Zhang; Xiao Hu; Ruyong Yao; Chuandong Sun; Chengzhan Zhu
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

4.  Naringin Decreases TNF-α and HMGB1 Release from LPS-Stimulated Macrophages and Improves Survival in a CLP-Induced Sepsis Mice.

Authors:  Minchan Gil; Yun Kyu Kim; Sang Bum Hong; Kyung Jin Lee
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

5.  Tim-3 deteriorates neuroinflammatory and neurocyte apoptosis after subarachnoid hemorrhage through the Nrf2/HMGB1 signaling pathway in rats.

Authors:  Shenquan Guo; Yuanzhi Li; Boyang Wei; Wenchao Liu; Ran Li; Wenping Cheng; Xin Zhang; Xuying He; Xifeng Li; Chuanzhi Duan
Journal:  Aging (Albany NY)       Date:  2020-11-07       Impact factor: 5.682

6.  The Time-Course of Antioxidant Irisin Activity: Role of the Nrf2/HO-1/HMGB1 Axis.

Authors:  Agnieszka Irena Mazur-Bialy; Ewa Pocheć
Journal:  Antioxidants (Basel)       Date:  2021-01-11

Review 7.  Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway.

Authors:  Bercis Imge Ucar; Gulberk Ucar; Sarmistha Saha; Brigitta Buttari; Elisabetta Profumo; Luciano Saso
Journal:  Antioxidants (Basel)       Date:  2021-05-21

8.  Lipoxin A4 Preconditioning Attenuates Intestinal Ischemia Reperfusion Injury through Keap1/Nrf2 Pathway in a Lipoxin A4 Receptor Independent Manner.

Authors:  Xue Han; Weifeng Yao; Zipeng Liu; Haobo Li; Zhong-Jun Zhang; Ziqing Hei; Zhengyuan Xia
Journal:  Oxid Med Cell Longev       Date:  2016-06-07       Impact factor: 6.543

9.  Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress.

Authors:  Yao Wang; Qian Chen; Chunxia Shi; Fangzhou Jiao; Zuojiong Gong
Journal:  Mol Med Rep       Date:  2019-09-10       Impact factor: 2.952

10.  Dexmedetomidine Attenuates Orthotopic Liver Transplantation-Induced Acute Gut Injury via α 2-Adrenergic Receptor-Dependent Suppression of Oxidative Stress.

Authors:  Peibiao Lv; Tufeng Chen; Peibin Liu; Lei Zheng; Jingling Tian; Fan Tan; Jiaxin Chen; Yingqing Deng; Jun Li; Jun Cai; Xinjin Chi
Journal:  Oxid Med Cell Longev       Date:  2019-11-11       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.